Comparative acute efficacy and tolerability of OROS and immediate release formulations of methylphenidate in the treatment of adults with ADHD

被引：0
|
作者：
Biederman, J. [1 ]
Spencer, T. J. [1 ]
Mick, E. [1 ]
机构：
[1] Massachusetts Gen Hosp, Boston, MA 02114 USA
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2006年 / 16卷
关键词：
D O I：
10.1016/S0924-977X(06)70763-5
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S545 / S546
页数：2
相关论文
共 50 条
  • [11] Assessing Personality Disorder in Adults With ADHD, and its Effects on Response to Treatment with OROS® Methylphenidate (OROS® MPH)
    Robison, Reid
    Reimherr, Frederick W.
    Marchant, Barrie K.
    Gale, Phillip
    Williams, Erika D.
    Strong, Robert E.
    Halls, Corinne
    Soni, Poonam
    [J]. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2008, 18 (06) : 632 - 632
  • [12] Efficacy and safety of OROS® methylpheniclate in adults with ADHD:: the long-acting methylphenidate in adult ADHD (LAMDA) trial
    Roesler, M.
    Trott, G. E.
    Philipsen, A.
    Gerwe, M.
    Lee, E.
    Medori, R.
    Schauble, B.
    [J]. PHARMACOPSYCHIATRY, 2007, 40 (05) : 248 - 248
  • [13] OROS® formulation of methylphenidate in treatment for ADHD:: Duration of effect
    Wigal, SB
    [J]. PEDIATRIC RESEARCH, 2002, 51 (04) : 21A - 21A
  • [14] Efficacy outcomes during longterm prolonged-release methylphenidate treatment of adults with ADHD
    Imhof, L.
    Nyerod, H. J.
    Filipe, H. J.
    Dejonckheere, J.
    Waechter, S.
    Schaeuble, B.
    Buitelaar, J.
    Kooij, S.
    Casas, M.
    Van Oene, J. C.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2009, 19 : S353 - S354
  • [15] Comparison of the efficacy and safety of OROS® methylphenidate HCl with methylphenidate tid and placebo in children with ADHD
    Swanson, JM
    Wigal, SB
    Lerner, MA
    [J]. PEDIATRIC RESEARCH, 2000, 47 (04) : 34A - 34A
  • [16] Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults
    Candido, Raissa Carolina F.
    Menezes de Padua, Cristiane A.
    Golder, Su
    Junqueira, Daniela R.
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2021, (01):
  • [17] Optimizing methylphenidate delivery to improve treatment for ADHD:: Results with OROS® (methylphenidate HCl)
    Lerner, MA
    Modi, NB
    Gupta, S
    [J]. PEDIATRIC RESEARCH, 2000, 47 (04) : 29A - 29A
  • [18] Tolerability of OROS® MPH for treatment of ADHD plus epilepsy
    Gonzalez-Heydrich, Joseph M.
    Whitney, Jane E.
    Hsin, Olivia
    Rao, Sneha N.
    Mrakotsky, Christine
    Waber, Deborah P.
    MacMillan, Carlene M.
    Torres, Alcy R.
    Pravdova, Iva J.
    DeMaso, David R.
    Bourgeois, Blaise F. D.
    Biederman, Joseph J.
    [J]. ANNALS OF NEUROLOGY, 2006, 60 : S47 - S48
  • [19] Evaluation of efficacy and safety of OROS® methylphenidate HCl (MPH) extended-release tablets, methylphenidate tid, and placebo in children with ADHD
    Wolraich, ML
    [J]. PEDIATRIC RESEARCH, 2000, 47 (04) : 36A - 36A
  • [20] A COMPARISON OF METHYLPHENIDATE FORMULATIONS IN THE TREATMENT OF ADHD
    Shea, Sarah E.
    [J]. JOURNAL OF POPULATION THERAPEUTICS AND CLINICAL PHARMACOLOGY, 2006, 13 (01): : E63 - E64
12345